Women Focused Encounters for Resilience Independence Strength and Eudaimonia
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: 1. Is a woman 2. Able to read and understand English 3. Able to participate in a low intensity exercise program 4. HIV-seropositive 5. At risk substance use (any illegal or unprescribed drug), tobacco, marijuana or alcohol use (four or more drinks in one day or 8 or more in one week). 6. Reports missing more ART doses than previous months, or \> 5 in a month, or has a detectable HIV viral load 7. Experienced interpersonal violence 8. Able and willing to provide informed consent Exclusion Criteria: 1. Unwilling to participate in video record sessions (used to evaluate the quality of the intervention) 2. Enrolled in hospice 3. Not willing or not able to comply with study advisory board group participation agreement.
About the study
The goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and commitment therapy (ACT) + exercise + social support to address the substance (ab)use, violence, and AIDS/HIV (SAVA) to improve medication adherence for women living with HIV (WLWH). This intervention will be implemented by community based organizations that focus on WLWH across four counties. The main question it aims to answer are:
* Will peer provision of ACT, exercise, and social support improve medication adherence for WLWH? * Will community based organizations be able to sustain the intervention after research is completed, and what changes will need to be made to sustain the intervention.
What is being tested
- Acceptance and Commitment Therapy (ACT) (behavioral)
- Body weight circuit training (behavioral)
- Empathetic social support (behavioral)
- Control - list of resources (other)
Sponsor: University of California, San Diego · Participants: 300 · Started: Sep 19, 2024
Contact the study team
- Liliana Harkness · Phone: 619-543-4753
- Helene Le · Phone: 619-543-3116
Official record on ClinicalTrials.gov — NCT06216600
Locations in the U.S.
| California | UC San Diego AntiViral Research Center (AVRC), San Diego |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.